| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.29 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |